Emerging Treatment Options for B-cell Lymphomas
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Discuss the mechanism action, safety and efficacy of novel targeted therapies and their potential role in the management of patients with relapsed or refractory NHLs
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
- 0.75 Participation
- 0.83 Nurse
- 0.75 Pharmacist
- 0.75 Physician